Schizophrenia does not appear suddenly from nowhere. It develops over years, often decades, through a cascade of genetic vulnerabilities, prenatal exposures, brain maturation processes, and environmental triggers that accumulate long before anyone hears voices or loses touch with reality. The condition affects roughly one in a hundred people worldwide, yet no two paths to it look exactly the same. What researchers have pieced together is less a single cause and more a layered story of risk, one that begins before birth and reaches a tipping point most often in late adolescence or early adulthood.
The Genetic Foundation
Schizophrenia runs in families, but not in the straightforward way that, say, cystic fibrosis does. There is no single “schizophrenia gene.” Instead, hundreds of common genetic variants, each contributing a tiny nudge in risk, pile up alongside rarer but more powerful mutations. Both common variants (single-nucleotide polymorphisms scattered across the genome) and rare copy number variants contribute to liability, and the relationship between these two types of genetic risk is still being worked out.1PubMed Central. Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia Research on patients who carry well-known risk mutations like the 22q11.2 deletion has found that these individuals sometimes have lower polygenic risk scores overall, suggesting the rare mutation alone was powerful enough to push them across the threshold without as much help from common variants.2PubMed Central. Polygenic risk scores in schizophrenia with clinically significant copy number variants
The practical takeaway is that genetic risk exists on a spectrum. Some people carry a heavy genetic load and need fewer environmental hits to develop the disorder. Others carry a lighter load but accumulate enough environmental exposure to tip the balance. This “threshold model” explains why schizophrenia can seem to skip generations, appear in families with no known history, or affect one identical twin but not the other.
What Happens Before Birth
The developmental clock for schizophrenia risk starts ticking in the womb. Infections during pregnancy can trigger what researchers call maternal immune activation, where the mother’s immune response floods the developing fetal brain with inflammatory signals. Animal studies have shown that this immune activation produces schizophrenia-like behavioral changes in offspring through inflammatory, oxidative, and cell-death pathways.3PubMed. Maternal Immune Activation Causes Schizophrenia-like Behaviors in the Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic Pathways, and Lowered Antioxidant Defenses and Neuroprotection The mechanism appears to reach the genetic level: maternal immune activation in mice leads to the downregulation of genes already associated with schizophrenia risk through genome-wide association studies.4Brain Communications. Maternal immune activation downregulates schizophrenia genes in the foetal mouse brain
This does not mean that every pregnancy complicated by the flu or another infection leads to schizophrenia. The vast majority do not. But in a fetus already carrying genetic vulnerability, prenatal immune disruption can lay down subtle alterations in brain wiring that may not show consequences for another fifteen or twenty years. Obstetric complications like oxygen deprivation during delivery and low birth weight have also been linked to elevated risk, though the effect sizes are modest. These early insults seem to prime the brain for trouble rather than cause illness on their own.
The Adolescent Brain and Synaptic Pruning
One of the most compelling pieces of the puzzle involves a normal process that goes wrong. During adolescence, the brain undergoes massive synaptic pruning, eliminating connections it no longer needs to make the remaining circuits faster and more efficient. The complement system, a branch of the immune system better known for tagging pathogens for destruction, also tags synapses for removal during this period. In people who develop schizophrenia, this pruning appears to be excessive.
Research has found overexpression of a complement protein called C4 across several brain regions in patients with schizophrenia, supporting the idea that excessive complement activity disrupts normal pruning during adolescence.5PubMed. Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia The number of C4A gene copies a person carries correlates with greater neuropil contraction, essentially more aggressive pruning, in the prefrontal cortex and other regions critical for higher-order thinking.6PubMed Central. Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study This helps explain why schizophrenia so often emerges in the late teens and early twenties: the brain is losing connections it should have kept, and the damage becomes functionally apparent just as pruning peaks.
The structural consequences are visible on brain scans. Meta-analyses of structural MRI studies show that people with schizophrenia have lower grey matter volumes and thinner cortex compared to healthy controls. The differences are modest in absolute terms, around 7% in frontal and temporal regions and about 2% for whole-brain grey matter, but they are progressive over time and detectable early in the illness. Grey matter loss in people at clinical high risk is even linked to whether they later transition to full psychosis.7PubMed Central. Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes – Section: Summary of structural MRI findings and consideration of their implications
Environmental Triggers That Push People Over the Edge
Genetics and early brain development set the stage, but for many people, specific environmental exposures act as the final push. Cannabis use is one of the most studied triggers. The relationship between cannabis and psychosis is not simply that the drug causes hallucinations while someone is high. Evidence points to a genuine gene-environment interaction: the amount, potency, duration of use, and particularly the age of first exposure all matter, and genetic factors, including variations in the COMT gene, influence how vulnerable a person’s brain is to the psychosis-promoting effects of cannabis.8PubMed Central. Gene-environment interplay between cannabis and psychosis9European Psychiatry. Exploring the causal relationship between cannabis and schizophrenia: what is the role of genes and environment? Adolescent use is especially concerning because it overlaps with the critical pruning period described above.
Psychosocial stress is another major environmental contributor. Childhood trauma, including abuse, neglect, and household instability, has been repeatedly linked to higher psychosis risk. Growing up in an urban environment appears to compound this effect. Urban childhood may create additional stress exposure through higher rates of social isolation and what researchers call social defeat, the chronic feeling of being excluded or subordinated. These stressors alter the body’s stress-response system, and when layered on top of childhood adversity, the combined burden on stress regulation may become too much for a vulnerable brain.10PubMed Central. Childhood trauma and childhood urbanicity in relation to psychotic disorder
The Slow Build Before Psychosis
Schizophrenia rarely begins with a dramatic break from reality. Years before the first psychotic episode, subtle changes are often already underway. Cognitive impairment, particularly in processing speed and executive function, is detectable before any obvious signs of illness and is already as severe at the time of the first psychotic episode as it is years later.11PubMed Central. When does cognitive decline occur in the period prior to the first episode of schizophrenia?12PubMed. Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode This finding is striking because it suggests that much of the cognitive damage happens during development, not as a consequence of psychosis itself.
The prodromal phase, the period of declining function that precedes full psychosis, can last months or years. A person might become increasingly withdrawn, suspicious, or preoccupied with unusual ideas. Sleep patterns shift. Academic or work performance drops. These changes are nonspecific enough that they are often attributed to depression, adolescent moodiness, or substance use. Specialized “ultra high risk” clinics have been developed to identify people in this prodromal window, and earlier detection has contributed to a declining rate of transition to full psychosis over time, with each successive year showing a transition rate roughly 0.80 times that of the preceding year, partly because people are getting help sooner.13PubMed Central. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?
Sleep and circadian disruption often appear during this prodromal period and may be more than just a symptom. Abnormal sleep patterns affect brain plasticity and cognition and frequently precede a formal diagnosis, leading researchers to propose that circadian disruption plays an active role in the pathway toward psychosis rather than being a passive byproduct.14PubMed. Do sleep abnormalities and misaligned sleep/circadian rhythm patterns represent early clinical characteristics for developing psychosis in high risk populations?
Why Onset Timing Differs Between Men and Women
Men tend to develop schizophrenia earlier than women, typically in their late teens to early twenties, while women often experience onset in their mid-to-late twenties. Women also show a second, smaller peak of new cases around menopause. The most widely researched explanation involves estrogen. The estrogen protection hypothesis proposes that estrogen buffers the brain against the development and severity of schizophrenia, and the clinical pattern fits: women are relatively protected during their reproductive years when estrogen levels are high, then become more vulnerable as levels decline.15PubMed Central. A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings
Within women’s illness course, symptom severity tends to fluctuate with hormonal phases: periods of high estrogen correlate with fewer and less severe symptoms, while low-estrogen phases correlate with exacerbations.16PubMed Central. The role of estrogen in schizophrenia This does not mean women have a milder form of schizophrenia overall. The clinical presentation is different rather than necessarily less severe, with women sometimes showing more mood-related symptoms and men showing more pronounced negative symptoms like emotional flatness and social withdrawal.17PubMed Central. Estrogens in schizophrenia: progress, current challenges and opportunities
The Role of Neuroinflammation
Beyond the complement-driven pruning story, broader neuroinflammation appears to be a running theme across the illness. Microglia, the brain’s resident immune cells, show increased density and activation at various stages of schizophrenia, not just during the adolescent pruning window.18PubMed Central. Microglial activation and progressive brain changes in schizophrenia Both genetic risk factors and environmental exposures like infection and stress appear to converge on microglial activation, elevated inflammatory signaling molecules, and activation of the inflammasome, producing an overall heightened neuroinflammatory state.19PubMed Central. Microglia-neuron interactions in schizophrenia This neuroinflammation has been proposed as one mechanism driving the progressive grey matter loss seen on brain scans, suggesting the immune system does not just help trigger the illness but may continue to damage the brain as it progresses.
Neurotransmitter Disruption
For decades, the dominant explanation for schizophrenia focused on dopamine: too much of it in certain brain circuits was thought to cause psychotic symptoms. This model explained why antipsychotic drugs, which block dopamine receptors, reduce hallucinations and delusions. But the dopamine story was always incomplete because it could not account for the cognitive problems and negative symptoms that antipsychotics barely touch. A more unified hypothesis proposes that reduced functioning of glutamate receptors, specifically NMDA receptors, is a key upstream mechanism that helps explain both the psychotic symptoms and the cognitive and motivational deficits.20Archives of General Psychiatry. Glutamate Receptor Dysfunction and Schizophrenia This framework views dopamine dysregulation as partly downstream of glutamate problems, rather than the root cause.
Disrupted communication between brain networks adds another layer. Neuroimaging studies have revealed abnormal connectivity between the thalamus, a deep brain structure that acts as a relay hub, and the cortical networks responsible for attention, self-referential thought, and executive control. These connectivity disruptions are present in first-episode patients and, to a lesser degree, in people at clinical high risk who have not yet developed psychosis, suggesting the wiring problems precede full illness.21Oxford Academic (Schizophrenia Bulletin). Large-Scale Thalamocortical Triple Network Dysconnectivities in Patients With First-Episode Psychosis and Individuals at Risk for Psychosis
Why Speed of Treatment Matters So Much
Once psychosis breaks through, every week counts. The duration of untreated psychosis, the gap between the first psychotic symptoms and the start of treatment, is one of the strongest predictors of long-term outcome. A large meta-analysis found that longer delays before treatment were associated with more severe positive symptoms, more severe negative symptoms, worse overall functioning, and a lower chance of remission. The effects are clinically meaningful: a delay of four weeks predicted over 20% more severe symptoms at follow-up compared to a delay of just one week.22PubMed Central. The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis
A systematic review of first-episode cohorts showed a distinctive temporal pattern: the relationship between treatment delay and poor outcome was weak at baseline but strengthened steadily over the following months. By six months, longer delays correlated with worse scores across virtually all measured outcomes. Patients with long untreated psychosis were also significantly less likely to achieve remission at every follow-up point examined.23JAMA Psychiatry. Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients: A Systematic Review The implication is clear: untreated psychosis appears to be actively harmful to the brain, and reducing that window is one of the most actionable things the mental health system can do.
The Gut-Brain Connection
A more recent and still-emerging line of research involves the gut microbiome. Patients with schizophrenia show a distinct gut bacterial profile compared to healthy controls, with lower levels of beneficial bacteria like Bifidobacterium and Lactobacillus species and higher levels of certain Clostridium species.24PubMed. Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia These microbial differences are linked to changes in tryptophan metabolism. People with schizophrenia tend to have lower blood levels of tryptophan, the amino acid the body uses to make serotonin, and higher levels of kynurenic acid, a tryptophan byproduct that affects glutamate signaling. The abundances of schizophrenia-enriched bacterial species correlated with these shifted metabolite levels, suggesting the gut microbiome may influence brain chemistry through this metabolic route.25Nature Communications. Metagenome-wide association of gut microbiome features for schizophrenia
Whether gut bacteria changes are a cause, a consequence, or a feedback loop remains an open question. Antipsychotic medications themselves alter the microbiome, and diet, stress, and lifestyle differences between patients and healthy controls muddy the picture. But the connection to tryptophan and glutamate pathways gives it biological plausibility worth tracking.
Not Everyone Follows the Same Trajectory
One of the biggest misconceptions about schizophrenia is that it is inevitably degenerative, a steady downhill slide from first episode to chronic disability. The reality is more varied. Research increasingly frames schizophrenia as a neurodevelopmental disorder that can follow multiple trajectories, some of them progressive and some relatively stable after the initial decline.26Brazilian Journal of Psychiatry. Heterogeneous trajectories in schizophrenia: insights from neurodevelopment and neuroprogression models Some people experience a single episode and recover well. Others cycle between episodes and partial recovery. A smaller proportion does follow a chronic deteriorating course.
What shapes these different trajectories? Genetics, treatment speed, and something called cognitive reserve all play roles. Cognitive reserve, built through education, intellectual engagement, and social activity before illness onset, appears to delay the point at which brain changes cross the threshold into clinical symptoms. People with higher cognitive reserve may develop schizophrenia later, show less severe symptoms, and maintain better day-to-day functioning throughout the illness.27Neuroscience & Biobehavioral Reviews. Influence of cognitive reserve in schizophrenia: A systematic review This finding has practical implications: enriching cognitive and social environments for at-risk young people could genuinely shift outcomes even if it does not prevent the illness entirely.
Why Schizophrenia Genes Persist in the Population
Given its severity and the reproductive disadvantage it confers, the persistence of schizophrenia-related genetic variants across millennia has puzzled evolutionary biologists. One explanation gaining traction is that these variants hitchhiked alongside genes that were positively selected during human evolution. Research has shown that genomic regions associated with schizophrenia risk tend to sit in stretches of DNA that diverge from Neanderthal sequences, meaning they are part of what makes us distinctly human.28PubMed Central. Genetic markers of human evolution are enriched in schizophrenia The implication is that schizophrenia susceptibility may be a side effect of evolutionary innovations like language and complex abstract thought.
Supporting this, analyses of genes linked to schizophrenia have found evidence of positive selection in the primate lineage, consistent with the idea that these genes were advantageous before they were harmful, and only become harmful in certain combinations or under certain environmental pressures.29PubMed Central. Adaptive evolution of genes underlying schizophrenia This does not romanticize the disorder; schizophrenia remains devastating. But it does suggest that eradicating the genetic variants involved might be neither possible nor desirable, since they overlap with the very capabilities that define human cognition.